| Term 
 
        | BZD used for anxiety that has a cyclopropyl group |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD used primarily for anxiety that has a trifluromethyl group |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD used for insomnia that has a tertiary amine group |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD Prodrug of oxazepam used for PARTIAL seizures, anxiety and withdrawal symptoms that has a carboxyl group at C-3 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Thioamide (-N-C=O-C=S-)BZD that contains a trifluromethyl group used primarily for insomnia that has a trifluromethyl group |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD used to treat all types of seizure EXCEPT grand mal that contains a nitro group |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD that can undergo hydrolysis into a lactam N----->O |  | Definition 
 
        | Chlordiazepoxide (Librax, Librium) |  | 
        |  | 
        
        | Term 
 
        | BZDs containing a triazole ring that is used for many types of seizures EXCEPT grand mal |  | Definition 
 
        | Triazolam, Alprazolam, Estazolam |  | 
        |  | 
        
        | Term 
 
        | BZD containing an imidazole ring used for preoperative sedation and for IV anesthesia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NonBZD carbamate sleep aid that has a chiral center and only the S configuration is used. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Non-BZD sleep aid with shorten sleep latency, prolonged sleep time and has no effect on stages of sleep that contains an imidazopyridine ring |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BZD competitive antagonist that contains an imidazole ring  that is used for BZD overdose (blocks both agonists and inverse agonists) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Partial inverse agonist that freezes BZD receptors, close CL- channels and decrease conductance |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Only Structural difference between Romazicon and RO 15-4513` |  | Definition 
 
        | Romazicon has a X=F- and RO 15-4513 has X=N3 |  | 
        |  | 
        
        | Term 
 
        | Why is RO 15-4513 considered an agonist and not an antagonist? |  | Definition 
 
        | Because it actually binds to a receptor and not just blocks it although it result in antagonistic effects such as closing of CL- channel |  | 
        |  | 
        
        | Term 
 
        | Location of serotonin receptors |  | Definition 
 | 
        |  |